AstraZeneca, Ionis report major trial failure with heart disease drug
Context
AstraZeneca, Ionis report major trial failure with heart disease drug STAT AstraZeneca and Ionis Stock Slump After Trial Miss Is an Overreaction Barron's AstraZeneca stock drops 9% after heart drug trial miss deals rare blow to pharma powerhouse CNBC AstraZeneca's Wainua fails key heart disease trial, shares tumble Reuters Crude oil prices rise again while UK stock market falls, dragged down by AstraZeneca – as it happened The Guardian
What it means
A major late-stage trial failure for AstraZeneca and Ionis's heart disease drug has historically been associated with sharp single-stock selloffs for both companies, as the market reprices the lost revenue potential. AstraZeneca's heavy weighting in the FTSE 100 means the UK index also sees near-term drag. Barron's framing of the drop as an overreaction suggests some analysts see medium-term recovery potential, but near-term pressure is the dominant signal.
Causal chain
- Exp. moveTimeframeConviction
- AstraZeneca (AZN)$171.34L1d
Major Phase III trial failure eliminates near-term revenue expectations for Wainua in heart disease
✓ correct-6%(abnormal -6.0%)·1 trading day (8 Jul → 9 Jul)·$189.28 → $178.49 - Ionis Pharmaceuticals (IONS)$53.28L1d
As co-developer and royalty partner, Ionis loses a key pipeline asset and revenue stream
✓ correct-24%(abnormal -24.3%)·1 trading day (8 Jul → 9 Jul)·$84.46 → $64.27 AZN is a large FTSE 100 constituent; its ~9% drop drags the broader UK equity index
not scoreable · excluded from accuracy
How to read a signal
- Severity
- the event's market impact, 1–5
- Direction
- ↑ / ↓ likely price move for the asset
- Exp. move
- the size of the abnormal move we'd expect if the call plays out — not a claim a move will happen:Most flagged events don't move beyond noise; those count against us (see the track record).Ssmall<1%Mmoderate1–5%Llarge>5%
- Timeframe
- the window we measure over:1dshort5dmedium21dlong
- Conviction
- how well-established the directional call is (textbook → speculative) — not a guaranteed outcome:lowaveragestrong
Get the next signal the moment it breaks.
The full live feed, asset filters, and alerts — free.
Sign up free →Not investment advice · for informational purposes only. Generated 9 Jul, 22:10 UTC